BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32984834)

  • 1. Does Pulmonary Aspergillosis Complicate Coronavirus Disease 2019?
    Beer KD; Jackson BR; Chiller T; Verweij PE; Van de Veerdonk FL; Wauters J
    Crit Care Explor; 2020 Sep; 2(9):e0211. PubMed ID: 32984834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 associated with pulmonary aspergillosis: A literature review.
    Lai CC; Yu WL
    J Microbiol Immunol Infect; 2021 Feb; 54(1):46-53. PubMed ID: 33012653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model.
    Seldeslachts L; Vanderbeke L; Fremau A; Reséndiz-Sharpe A; Jacobs C; Laeveren B; Ostyn T; Naesens L; Brock M; Van De Veerdonk FL; Humblet-Baron S; Verbeken E; Lagrou K; Wauters J; Vande Velde G
    Virulence; 2021 Dec; 12(1):2493-2508. PubMed ID: 34546839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections.
    Ku YH; Chan KS; Yang CC; Tan CK; Chuang YC; Yu WL
    J Formos Med Assoc; 2017 Sep; 116(9):660-670. PubMed ID: 28647219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
    Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
    Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillus coinfection in critically Ill patients with severe dengue.
    Lin YH; Chang TC; Yu WL; Chou W; Chen CM
    J Infect Public Health; 2023 Dec; 16(12):1893-1897. PubMed ID: 37866267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of patients with coronavirus disease 2019-associated pulmonary aspergillosis on mechanical ventilation: A single-center retrospective study in Japan.
    Ogawa Y; Murata K; Hasegawa K; Nishida K; Gohma I; Kasahara K
    J Infect Chemother; 2023 Mar; 29(3):239-243. PubMed ID: 36379404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.
    Verweij PE; Rijnders BJA; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Calandra T; Clancy CJ; Cornely OA; Chiller T; Depuydt P; Giacobbe DR; Janssen NAF; Kullberg BJ; Lagrou K; Lass-Flörl C; Lewis RE; Liu PW; Lortholary O; Maertens J; Martin-Loeches I; Nguyen MH; Patterson TF; Rogers TR; Schouten JA; Spriet I; Vanderbeke L; Wauters J; van de Veerdonk FL
    Intensive Care Med; 2020 Aug; 46(8):1524-1535. PubMed ID: 32572532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus.
    Steenwyk JL; Mead ME; de Castro PA; Valero C; Damasio A; Dos Santos RAC; Labella AL; Li Y; Knowles SL; Raja HA; Oberlies NH; Zhou X; Cornely OA; Fuchs F; Koehler P; Goldman GH; Rokas A
    Microbiol Spectr; 2021 Sep; 9(1):e0001021. PubMed ID: 34106569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive care management of influenza-associated pulmonary aspergillosis.
    Koehler P; Bassetti M; Kochanek M; Shimabukuro-Vornhagen A; Cornely OA
    Clin Microbiol Infect; 2019 Dec; 25(12):1501-1509. PubMed ID: 31102782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.
    Bretagne S; Sitbon K; Botterel F; Dellière S; Letscher-Bru V; Chouaki T; Bellanger AP; Bonnal C; Fekkar A; Persat F; Costa D; Bourgeois N; Dalle F; Lussac-Sorton F; Paugam A; Cassaing S; Hasseine L; Huguenin A; Guennouni N; Mazars E; Le Gal S; Sasso M; Brun S; Cadot L; Cassagne C; Cateau E; Gangneux JP; Moniot M; Roux AL; Tournus C; Desbois-Nogard N; Le Coustumier A; Moquet O; Alanio A; Dromer F;
    Microbiol Spectr; 2021 Oct; 9(2):e0113821. PubMed ID: 34668768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics, bacterial coinfections and outcomes in COVID-19-associated pulmonary aspergillosis in a third-level Mexican hospital during the COVID-19 pre-vaccination era.
    Hernández-Silva G; Corzo-León DE; Becerril-Vargas E; Peralta-Prado AB; Odalis RG; Morales-Villarreal F; Ríos-Ayala MA; Alonso TG; Agustín FD; Ramón AF; Hugo AV
    Mycoses; 2024 Jan; 67(1):e13693. PubMed ID: 38214372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.
    Schauwvlieghe AFAD; Rijnders BJA; Philips N; Verwijs R; Vanderbeke L; Van Tienen C; Lagrou K; Verweij PE; Van de Veerdonk FL; Gommers D; Spronk P; Bergmans DCJJ; Hoedemaekers A; Andrinopoulou ER; van den Berg CHSB; Juffermans NP; Hodiamont CJ; Vonk AG; Depuydt P; Boelens J; Wauters J;
    Lancet Respir Med; 2018 Oct; 6(10):782-792. PubMed ID: 30076119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
    Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
    J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pathology-based Case Series of Influenza- and COVID-19-associated Pulmonary Aspergillosis: The Proof Is in the Tissue.
    Vanderbeke L; Jacobs C; Feys S; Reséndiz-Sharpe A; Debaveye Y; Hermans G; Humblet-Baron S; Lagrou K; Meersseman P; Peetermans M; Seldeslachts L; Vanstapel A; Vande Velde G; Van Wijngaerden E; Wilmer A; Verbeken E; De Hertogh G; Wauters J
    Am J Respir Crit Care Med; 2023 Aug; 208(3):301-311. PubMed ID: 37311243
    [No Abstract]   [Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal VAP-related pulmonary aspergillosis by
    Trovato L; Calvo M; Migliorisi G; Astuto M; Oliveri F; Oliveri S
    Respir Med Case Rep; 2021; 32():101367. PubMed ID: 33619451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Associated Pulmonary Aspergillosis: A Case Series.
    Yulianti M; Johan C; Tenda ED; Singh G; Herikurniawan H; Wijaya IPEK
    Acta Med Indones; 2022 Apr; 54(2):292-298. PubMed ID: 35818652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature.
    Shah MM; Hsiao EI; Kirsch CM; Gohil A; Narasimhan S; Stevens DA
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):147-152. PubMed ID: 29454654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspergillosis Complicating Severe Coronavirus Disease.
    Marr KA; Platt A; Tornheim JA; Zhang SX; Datta K; Cardozo C; Garcia-Vidal C
    Emerg Infect Dis; 2021 Jan; 27(1):18-25. PubMed ID: 33084566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.